Detailed price information for Eranova Metals Inc (NOVA-X) from The Globe and Mail including charting and trades.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.

Almost five years after a New York college student was attacked by an unknown assailant who threw acid in her face, police have arrested a male suspect. Prosecutors say a rap song helped incriminate ...

DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing fo ...

Even a cursory read of the study will likely prompt questions, but let’s take the findings at face value based on what was ...

We may earn commission from links on this page, but we only recommend products we love. Promise. So we all know hyaluronic acid to be the MVP of skincare—or, at least, that’s what you’ve ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Jani Hall is a news editor for Health with a background in health and science journalism. Previously, she worked as a staff reporter for National Geographic. William Truswell, MD, FACS, operates his ...

Cars are worth less after a crash, even if repairs make it seem "good as new." A diminished value insurance claim pays you the difference between what your car was worth before the accident and what ...

Because Santa Clara University is rooted in Catholic and Jesuit traditions, we welcome students wherever they come from, wherever they are, and wherever they are heading. As part of a global network ...

Start by thinking about the dilemmas your people will face. by Erin Meyer At the beginning of my career, I worked for the health-care-software specialist HBOC. One day, a woman from human resources ...

Growth stocks outperformed their value counterparts for much of 2025, but that trend started to shift toward the end of the year. Value stocks have seen more consistent returns heading into 2026. They ...